Syncom Formulation (India) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

20.41

-0.74 (-3.50%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

20.41

-0.74 (-3.50%)
16:02 Dec 20

Quality

77/100
High Financial Strength

Valuation

22/100
Expensive Valuation

Technical

62/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2017	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	184.82	219.66	224.25	263.39	329.28
Operating Expenses +	168.33	199.62	204.62	233.75	289.9
Raw Material	123.14	137.22	142.07	158.64	223.71
Increase Decrease in Cost	4.97	3.32	-0.38	-1.75	-21.16
Other Manufacturing Expense	4.29	6.31	8.15	8.12	0
Employee Cost	14.62	22.16	25.87	35.06	40.48
Miscellaneous Expenses	129.55	110.23	114.13	87.9	46.87
Operating Profit	16.49	20.04	19.63	29.64	39.38
Other Income	2.79	11.99	14.6	13.53	13.15
Depreciation	3.12	3.95	4.54	4.72	5.35
Interest	0.28	1.93	3.13	4.47	2.83
Profit before tax and exceptio..	15.89	26.15	26.56	33.98	44.35
Exceptional Items	0	0.02	0.01	-0.02	-0.02
PBT	15.89	26.18	26.57	33.95	44.37
Provision for Taxation	5.34	6.39	6.5	8.64	11.2
Net Profit	10.53	19.79	20.07	25.31	33.14
NET Profit after MI	10.53	19.79	20.07	25.31	33.14
EPS	0.13	0.26	0.24	0.34	0.46
Operating Profit Margin (%)	8.92	9.12	8.75	11.25	11.96
Net Profit Margin (%)	5.7	9.01	8.95	9.61	10.06

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	50.60	50.60	50.60	50.60	50.60
FII	0.10	0.10	0.10	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	49.30	49.30	49.40	49.40	49.40
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	-0.10	0.00	0.00